ARCHIVES

DCE Board Ok’s New RFA Programs worth $14 Million

This article is from The Cancer Letter archive.

Vol. 16 No. 26 | June 29, 1990

Download PDF Visit The Full Archive

Related Articles

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

Interview: “People don’t understand Clinical Trials.

September 5, 1997

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013